Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?

Kato TA, Monji A, Mizoguchi Y, Hashioka S, Horikawa H, Seki Y, Kasai M, Utsumi H, Kanba S.

Mini Rev Med Chem. 2011 Jun;11(7):565-74. Review.

PMID:
21699487
2.

Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.

Kato T, Mizoguchi Y, Monji A, Horikawa H, Suzuki SO, Seki Y, Iwaki T, Hashioka S, Kanba S.

J Neurochem. 2008 Jul;106(2):815-25. doi: 10.1111/j.1471-4159.2008.05435.x. Epub 2008 Apr 19.

3.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
4.

Neuroinflammation in schizophrenia especially focused on the role of microglia.

Monji A, Kato TA, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, Yamauchi Y, Yamada S, Kanba S.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:115-21. doi: 10.1016/j.pnpbp.2011.12.002. Epub 2011 Dec 13. Review.

PMID:
22192886
5.

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia.

Monji A, Kato T, Kanba S.

Psychiatry Clin Neurosci. 2009 Jun;63(3):257-65. Review.

PMID:
19579286
6.

Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro.

Kato T, Monji A, Hashioka S, Kanba S.

Schizophr Res. 2007 May;92(1-3):108-15. Epub 2007 Mar 23.

PMID:
17363222
7.

Targeting the dopamine D2 receptor in schizophrenia.

Seeman P.

Expert Opin Ther Targets. 2006 Aug;10(4):515-31. Review.

PMID:
16848689
8.

Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.

Sanyal S, Van Tol HH.

J Psychiatr Res. 1997 Mar-Apr;31(2):219-32. Review.

PMID:
9278187
9.

Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia.

Kato TA, Monji A, Yasukawa K, Mizoguchi Y, Horikawa H, Seki Y, Hashioka S, Han YH, Kasai M, Sonoda N, Hirata E, Maeda Y, Inoguchi T, Utsumi H, Kanba S.

Schizophr Res. 2011 Jul;129(2-3):172-82. doi: 10.1016/j.schres.2011.03.019. Epub 2011 Apr 15.

PMID:
21497059
10.

Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.

Seki Y, Kato TA, Monji A, Mizoguchi Y, Horikawa H, Sato-Kasai M, Yoshiga D, Kanba S.

Schizophr Res. 2013 Dec;151(1-3):20-8. doi: 10.1016/j.schres.2013.09.011. Epub 2013 Oct 4.

PMID:
24100191
11.

[Redox and microglia in the pathophysiology of schizophrenia].

Kato TA, Hyodo F, Yamato M, Utsumi H, Kanba S.

Yakugaku Zasshi. 2015;135(5):739-43. doi: 10.1248/yakushi.14-00235-4. Review. Japanese.

12.

Dopamine D2 receptors as treatment targets in schizophrenia.

Seeman P.

Clin Schizophr Relat Psychoses. 2010 Apr;4(1):56-73. doi: 10.3371/CSRP.4.1.5. Review.

PMID:
20643630
13.

Novel pharmacological approaches to the treatment of schizophrenia.

Fink-Jensen A.

Dan Med Bull. 2000 Jun;47(3):151-67. Review.

PMID:
10913983
14.

Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes.

Joyce JN, Goldsmith SG, Gurevich EV.

J Psychiatr Res. 1997 Mar-Apr;31(2):197-217. Review.

PMID:
9278186
15.

All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors.

Seeman P.

CNS Neurosci Ther. 2011 Apr;17(2):118-32. doi: 10.1111/j.1755-5949.2010.00162.x.

PMID:
20560996
16.
17.

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.

Wong DF, Wagner HN Jr, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A.

Science. 1986 Dec 19;234(4783):1558-63. Erratum in: Science 1987 Feb 6;235(4789):623.

PMID:
2878495
18.

Monoamines and schizophrenia.

Sedvall G.

Acta Psychiatr Scand Suppl. 1990;358:7-13. Review.

PMID:
1978495
19.

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.

Wilson JM, Sanyal S, Van Tol HH.

Eur J Pharmacol. 1998 Jun 26;351(3):273-86. Review.

PMID:
9721018
20.

Dopamine D4 receptors and development of newer antipsychotic drugs.

Kulkarni SK, Ninan I.

Fundam Clin Pharmacol. 2000 Nov-Dec;14(6):529-39. Review.

PMID:
11206702

Supplemental Content

Support Center